Date and Time: January 6, 2026, 8AM ET Webcast: ...
Bright Minds Biosciences has debuted glowing phase 2 results for its lead anti-seizure asset, giving the biotech’s stock a ...
Shares of Bright Minds Biosciences rose after the company released positive topline results from its phase two trial of a treatment for patients with drug-resistant Absence Seizures and Developmental ...
BMB-101 demonstrated significant anti-seizure benefit in both cohorts with favorable safety and tolerability Absence: 73.1% ...
(NewsNation) — March 26 is Purple Day, a day dedicated to raising awareness about epilepsy worldwide. An estimated 50 million people worldwide are diagnosed with epilepsy, and seizures are the main ...
New research from North Carolina State University pinpoints the areas of the cerebral cortex that are affected in mice with absence epilepsy and shows that transplanting embryonic neural cells into ...
Changes Clinical Practice: In children with absence epilepsy, ethosuximide should be preferred as the first-line anticonvulsant. Childhood absence epilepsy is one of the most common epilepsy syndromes ...
At first, the teacher described her six-year-old student as absentminded, a daydreamer. The boy was having difficulty paying attention in class. As the teacher watched the boy closely, she realized ...
The areas of the cerebral cortex that are affected in mice with absence epilepsy have been pinpointed by research that also shows that transplanting embryonic neural cells into these areas can ...
New contributions to the field of epilepsy have opened a window into the cellular events that occur in the brain during absence seizures. At first, the teacher described her six-year-old student as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback